ADELINA SALINAS: Open Payments
NPI 1306393632 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$725 in 36 payments from 16 companies in 2025. Trend: 2023 $489 · 2024 $721 · 2025 $725
Food & beverage: $683Education: $43
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $97 |
| Amgen Inc. | 6 | $89 |
| Novo Nordisk Inc | 4 | $79 |
| Mannkind Corporation | 2 | $64 |
| Philips North America LLC | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| ABBVIE INC. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Paratek Pharmaceuticals, Inc. | 2 | $35 |
| PFIZER INC. | 2 | $35 |
Products named: MOUNJARO, AFREZZA, Respiratory, REXULTI, EVENITY, UBRELVY, NUZYRA, PAXLOVID.
Industry payments across TX — which companies pay providers there.
